Evidence map›Paper›PMID 34943086›Full record

ArticleAntioxidants (Basel, Switzerland)2021

Synergistic Effect of 3',4'-Dihidroxifenilglicol and Hydroxytyrosol on Oxidative and Nitrosative Stress and Some Cardiovascular Biomarkers in an Experimental Model of Type 1 Diabetes Mellitus.

José Pedro De La Cruz Cortés, Leticia Vallejo-Carmona, María Monsalud Arrebola, Esther Martín-Aurioles, María Dolores Rodriguez-Pérez, Laura Ortega-Hombrados, Cristina Verdugo, María África Fernández-Prior, Alejandra Bermúdez-Oria, José Antonio González-Correa

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

José Pedro De La Cruz CortésDepartmento de Farmacología, Instituto de Investigación Biomédica (IBIMA), Facultad de Medicina, Universidad de Málaga, 29010 Málaga, Spain.ORCID 0000-0002-9613-6660
Leticia Vallejo-CarmonaFacultad de Enfermería, Universidad Ana G. Mendez, Recinto Cupei, San Juan PR 00928, Puerto Rico.
María Monsalud ArrebolaUGC Laboratorio Clínico, Hospital de la Axarquía, AGSEMA, 29740 Málaga, Spain.ORCID 0000-0002-4843-0718
Esther Martín-AuriolesDistrito Sanitario Málaga-Guadalhorce, UGC La Roca, 29009 Málaga, Spain.
María Dolores Rodriguez-PérezDepartmento de Farmacología, Instituto de Investigación Biomédica (IBIMA), Facultad de Medicina, Universidad de Málaga, 29010 Málaga, Spain.
Laura Ortega-HombradosDepartmento de Farmacología, Instituto de Investigación Biomédica (IBIMA), Facultad de Medicina, Universidad de Málaga, 29010 Málaga, Spain.
Cristina VerdugoDepartmento de Farmacología, Instituto de Investigación Biomédica (IBIMA), Facultad de Medicina, Universidad de Málaga, 29010 Málaga, Spain.
María África Fernández-PriorConsejo Superior de Investigaciones Científicas (CSIC), Instituto de la Grasa, 41013 Seville, Spain.ORCID 0000-0002-8292-3081
Alejandra Bermúdez-OriaConsejo Superior de Investigaciones Científicas (CSIC), Instituto de la Grasa, 41013 Seville, Spain.ORCID 0000-0002-3632-3595
José Antonio González-CorreaDepartmento de Farmacología, Instituto de Investigación Biomédica (IBIMA), Facultad de Medicina, Universidad de Málaga, 29010 Málaga, Spain.ORCID 0000-0001-8862-3760
Instituto de Investigación Biomédica de Málaga · ESConsejo Superior de Investigaciones Científicas · ESAna G. Mendez University System · PR

Funding

Consejería de Salud. Junta de Andalucía (Spain), Proyectos de Investigación en Salud PI-0129-2017
6 · The paper itself

Abstract

The objective of this study was to assess a possible synergistic effect of two extra-virgin olive oil polyphenols, 3,4,-dyhydroxyphenylglycol (DHPG) and hydroxytyrosol (HT), in an experimental model of type 1 diabetes. Seven groups of animals were studied: (1) Nondiabetic rats (NDR), (2) 2-month-old diabetic rats (DR), (3) DR treated with 5 mg/kg/day p.o. HT, (4) DR treated with 0.5 mg/kg/day p.o. DHPG, (5) DR treated with 1 mg/kg/day p.o. DHPG, (6) DR treated with HT + DHPG (0.5), (7) DR treated with HT + DHPG (1). Oxidative stress variables (lipid peroxidation, glutathione, total antioxidant activity, 8-isoprostanes, 8-hydroxy-2-deoxyguanosine, and oxidized LDL), nitrosative stress (3-nitrotyrosine), and some cardiovascular biomarkers (platelet aggregation, thromboxane B

Indexed as

3′,4′-dihidroxifenilglicolcardiovascularextra-virgin olive oil polyphenolshydroxytyrosoloxidative stress

Identifiers

PMID34943086
PMCPMC8750252
OpenAlexW4200119771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.